
Navotaz M 4000mg/500mg Injection
Marketer
Naviksha Healthcare Pvt Ltd
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Navotaz M 4000mg/500mg Injection
Combiflox-M 4000mg/500mg injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, its dosage and frequency are determined by the physician based on individual health conditions. Strict adherence to prescribed usage is essential. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea), skin rashes, and localized injection site reactions (pain, swelling, redness). Persistent or worsening symptoms warrant immediate medical consultation. Prior to treatment, disclose any antibiotic allergies, liver, or kidney issues; adjustments to dosage or alternative medications may be necessary. While generally considered safe during pregnancy and lactation under medical guidance, professional supervision is crucial.
Primary Ingredients of Navotaz M 4000mg/500mg Injection
No text provided to rephrase.
Uses of Navotaz M 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Navotaz M 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Navotaz M 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Navotaz M 4000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Navotaz M 4000mg/500mg Injection works:
Navotaz M Injection (4000mg piperacillin/500mg tazobactam) combines the antibiotic piperacillin with the beta-lactamase inhibitor tazobactam. Piperacillin's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Navotaz M 4000mg/500mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Navotaz M (4000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Navotaz M (4000mg/500mg) presents no known breastfeeding contraindications. Research in humans indicates minimal to negligible drug transfer via breast milk, posing no apparent risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Navotaz M 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with kidney impairment, administration of Navotaz M 4000mg/500mg Injection requires careful monitoring. Dosage modification of Navotaz M 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Navotaz M 4000mg/500mg Injection in patients with liver impairment is likely safe. Available evidence indicates dose modification might not be necessary for this patient group. Physician consultation is recommended.
What if you forget to take Navotaz M 4000mg/500mg Injection :
Should you inadvertently skip a dose of Navotaz M 4000mg/500mg Injection, seek immediate medical advice.
Facts to Know About Navotaz M 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective agents |
